Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling Activity
Insider Ownership Percentage: 45.20%
Galectin Therapeutics (NASDAQ GALT) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/31/2019 | Jack W Callicutt | CFO | Buy | 2,354 | $4.28 | $10,075.12 | 3,614 |  |
| 5/31/2019 | Richard E Uihlein | Director | Buy | 4,680,606 | $4.28 | $20,032,993.68 | 3,128,489 | |
| 4/9/2019 | Richard E Uihlein | Director | Buy | 20,700 | $4.82 | $99,774.00 | 2,628,489 | |
| 4/5/2019 | Kevin D Freeman | Director | Buy | 500 | $4.73 | $2,365.00 | 22,043 | |
| 2/22/2019 | Marc Rubin | Director | Sell | 51,185 | $6.02 | $308,133.70 | 13,581 | |
| 2/8/2019 | Kevin D Freeman | Director | Buy | 1,500 | $4.29 | $6,435.00 | 22,043 | |
| 1/31/2019 | Gilbert F Amelio | Director | Sell | 30,000 | $5.00 | $150,000.00 | | |
| 1/29/2019 | Richard E Uihlein | Director | Buy | 51,500 | $4.87 | $250,805.00 | 2,538,289 | |
| 9/25/2018 | Kary Eldred | Director | Buy | 2,000 | $6.10 | $12,200.00 | 41,382 | |
| 9/10/2018 | Gilbert S Omenn | Director | Sell | 19,370 | $6.02 | $116,607.40 | 56,561 | |
| 9/7/2018 | Gilbert S Omenn | Director | Sell | 11,000 | $6.03 | $66,330.00 | 56,561 | |
| 9/4/2018 | Marc Rubin | Director | Sell | 11,900 | $6.58 | $78,302.00 | | |
| 8/30/2018 | Marc Rubin | Director | Sell | 58,100 | $6.08 | $353,248.00 | 84,581 | |
| 6/25/2018 | Joel Lewis | Director | Buy | 1,000 | $7.06 | $7,060.00 | 51,480 | |
| 6/20/2018 | Jack W Callicutt | CFO | Sell | 226,000 | $8.61 | $1,945,860.00 | 103,993 | |
| 6/18/2018 | Fund L.P. 10X | Major Shareholder | Sell | 151,860 | $8.61 | $1,307,514.60 | | |
| 6/18/2018 | James C Czirr | Director | Sell | 60,000 | $9.06 | $543,600.00 | | |
| 6/15/2018 | James C Czirr | Director | Sell | 15,475 | $8.47 | $131,073.25 | | |
| 6/14/2018 | Fund L.P. 10X | Major Shareholder | Sell | 76,385 | $8.28 | $632,467.80 | | |
| 6/13/2018 | Harold H Shlevin | COO | Sell | 43,698 | $7.41 | $323,802.18 | | |
| 6/13/2018 | James C Czirr | Director | Sell | 208,140 | $7.17 | $1,492,363.80 | | |
| 6/13/2018 | Peter G Traber | CEO | Sell | 100,000 | $7.51 | $751,000.00 | 207,333 | |
| 6/11/2018 | Harold H Shlevin | COO | Sell | 115,054 | $5.84 | $671,915.36 | 103,914 | |
| 6/11/2018 | Jack W Callicutt | CFO | Sell | 120,000 | $5.85 | $702,000.00 | 101,260 | |
| 6/8/2018 | Jack W Callicutt | CFO | Sell | 100,000 | $5.75 | $575,000.00 | 101,260 | |
| 6/8/2018 | James C Czirr | Director | Sell | 110,000 | $5.88 | $646,800.00 | | |
| 6/8/2018 | Peter G Traber | CEO | Sell | 70,000 | $5.86 | $410,200.00 | 177,333 | |
| 6/7/2018 | Harold H Shlevin | COO | Sell | 109,969 | $5.20 | $571,838.80 | 58,094 | |
| 6/5/2018 | Harold H Shlevin | COO | Sell | 20,831 | $5.15 | $107,279.65 | 59,414 | |
| 6/4/2018 | Fund L.P. 10X | Major Shareholder | Sell | 50,000 | $5.12 | $256,000.00 | | |
| 6/1/2018 | Harold H Shlevin | COO | Sell | 119,200 | $5.06 | $603,152.00 | 103,914 | |
| 5/31/2018 | Jack W Callicutt | CFO | Sell | 46,651 | $5.00 | $233,255.00 | 47,911 | |
| 4/16/2018 | Theodore Daniel Zucconi | Director | Sell | 4,000 | $3.58 | $14,320.00 | 5,083 | |
| 4/4/2018 | Jack W Callicutt | CFO | Sell | 3,349 | $5.00 | $16,745.00 | 4,609 | |
| 2/1/2018 | Kevin D Freeman | Director | Buy | 2,000 | $4.10 | $8,200.00 | 22,043 | |
| 1/26/2018 | Fund L.P. 10X | Major Shareholder | Sell | 244,444 | $5.43 | $1,327,330.92 | | |
| 1/25/2018 | James C Czirr | Director | Sell | 205,144 | $5.45 | $1,118,034.80 | | |
| 12/8/2017 | Marc Rubin | Director | Buy | 7,000 | $1.85 | $12,950.00 | 55,581 | |
| 5/23/2017 | Theodore Daniel Zucconi | Director | Buy | 1,000 | $2.27 | $2,270.00 | 1,083 | |
| 1/5/2016 | Arthur Greenberg | Director | Buy | 1,666 | $1.72 | $2,865.52 | 109,445 | |
| 8/12/2015 | Peter G Traber | CEO | Buy | 2,000 | $2.00 | $4,000.00 | | |
| 6/1/2015 | Kevin D Freeman | Director | Buy | 2,083 | $2.70 | $5,624.10 | | |
| 6/1/2015 | Peter G Traber | CEO | Buy | 4,000 | $2.53 | $10,120.00 | | |
| 8/19/2014 | Arthur Greenberg | Director | Buy | 1,000 | $4.56 | $4,560.00 | | |
| 8/15/2014 | Kevin D Freeman | Director | Buy | 1,000 | $4.70 | $4,700.00 | | |
| 8/14/2014 | Jack W Callicutt | CFO | Buy | 1,000 | $4.55 | $4,550.00 | | |
| 8/14/2014 | Peter G Traber | CEO | Buy | 4,000 | $4.46 | $17,840.00 | | |
| 8/13/2014 | Peter G Traber | CEO | Buy | 1,000 | $4.42 | $4,420.00 | | |
| 4/11/2014 | Steven Prelack | Director | Sell | 6,000 | $11.84 | $71,040.00 | | |
| 1/13/2014 | James C Czirr | Chairman | Sell | 100,000 | $14.84 | $1,484,000.00 | | |
| 12/4/2013 | Marc Rubin | Director | Buy | 3,000 | $8.69 | $26,070.00 | | |
| 11/19/2013 | Arthur Greenberg | Director | Buy | 2,000 | $6.55 | $13,100.00 | | |
| 11/19/2013 | Peter G Traber | CEO | Buy | 1,000 | $5.53 | $5,530.00 | | |
| 11/18/2013 | Peter G Traber | CEO | Buy | 1,000 | $5.80 | $5,800.00 | | |
| 11/15/2013 | James C Czirr | Chairman | Buy | 1,000 | $6.90 | $6,900.00 | | |
| 6/3/2013 | John F Mauldin | Director | Buy | 1,176 | $4.21 | $4,950.96 | | |
| 5/28/2013 | Kevin D Freeman | Director | Buy | 1,000 | $4.21 | $4,210.00 | | |
| 10/12/2012 | Peter G Traber | CEO | Buy | 2,500 | $2.11 | $5,275.00 | | |
| 10/9/2012 | Peter G Traber | CEO | Buy | 2,500 | $2.00 | $5,000.00 | | |
| 10/8/2012 | Peter G Traber | CEO | Buy | 5,000 | $2.07 | $10,350.00 | | |
(Data available from 1/1/2013 forward)
